Dr Vigrosky is testing the effectiveness of a new drug, called Xiptoflux, which is
supposed to alleviate certain symptoms which accompany restless leg syndrome.
Dr
Vigrosky gives one group of participants, who suffer from RLS, a drug which has
already been approved by the FDA. He gives another group of participants, who suffer
from RLS, the new drug, Xiptoflux. He found no significant difference between the
new drug and the old drug in terms of the alleviation of the symptoms of restless leg
syndrome. What aspect of Dr Vigrosky's design could be improved in subsequent trials
of the study?
A) He could have compared the two drugs to a third restless leg syndrome drug
B) He could have used an experimental group
C) He could have used a placebo control group
D) He could have given the new drug to a group of people who do not suffer from
RLS
Question 2
How were the animals in the study by Terkel and Rosenblatt ( 1968 ) treated
differently?
A) amount of food
B) amount of exercise
C) type of injection
D) type of environment
Testing complementation by using a heterokaryon
3.6 Vaginal drug administration: (a) instilling a vaginal suppository
Health History Assessment Questions Pertinent to Drug Administration
Example of “drug facts” labeling on the box of an OTC drug.
Testing cranial nerves IX and X
Testing rapid alternating movement, palm down